Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Charmacy Pharmaceutical Co., Ltd. Class H ( (HK:2289) ).
Charmacy Pharmaceutical Co., Ltd. announced a proposed change of auditors due to the approaching end of ShineWing’s service term, in compliance with the Administrative Measures for Selection and Appointment of Accounting Firms. ShineWing, the current auditor since 2017, will resign following the upcoming extraordinary general meeting. The company has proposed appointing Pan-China Certified Public Accountants LLP as the new auditor, subject to shareholder approval. The Board and Audit Committee believe Pan-China’s industry experience and technical competence align with the company’s audit requirements, ensuring no compromise in audit standards or effectiveness.
More about Charmacy Pharmaceutical Co., Ltd. Class H
Charmacy Pharmaceutical Co., Ltd. is a joint stock limited liability company established in China, operating in the pharmaceutical industry. The company, along with its subsidiaries, is involved in the production and distribution of pharmaceutical products.
Average Trading Volume: 27,352
Technical Sentiment Signal: Sell
Current Market Cap: HK$644.8M
For an in-depth examination of 2289 stock, go to TipRanks’ Overview page.